comparemela.com

Latest Breaking News On - Earnings history for alnylam pharmaceuticals - Page 1 : comparemela.com

Alnylam Pharmaceuticals (NASDAQ:ALNY) Releases Quarterly Earnings Results, Beats Expectations By $0 23 EPS

Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) posted its earnings results on Thursday. The biopharmaceutical company reported ($0.52) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.75) by $0.23, Briefing.com reports. The firm had revenue of $494.33 million for the quarter, compared to analyst estimates of $428.01 million. During the same […]

Alnylam Pharmaceuticals (NASDAQ:ALNY) Issues Earnings Results

Alnylam Pharmaceuticals (NASDAQ:ALNY) Issues Earnings Results
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Alnylam Pharmaceuticals (ALNY) to Release Earnings on Thursday

Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) is scheduled to issue its quarterly earnings data before the market opens on Thursday, May 2nd. Analysts expect the company to announce earnings of ($0.75) per share for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link. Alnylam […]

Alnylam Pharmaceuticals (ALNY) Scheduled to Post Earnings on Thursday

Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens on Thursday, May 2nd. Analysts expect Alnylam Pharmaceuticals to post earnings of ($0.75) per share for the quarter. Investors interested in participating in the company’s conference call can do so using this link. Alnylam Pharmaceuticals […]

Alnylam Pharmaceuticals (NASDAQ:ALNY) Announces Earnings Results, Beats Estimates By $0 57 EPS

Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Rating) issued its quarterly earnings results on Thursday. The biopharmaceutical company reported ($1.40) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($1.97) by $0.57, Briefing.com reports. The business had revenue of $319.29 million during the quarter, compared to analyst estimates of $312.53 million. Alnylam Pharmaceuticals had […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.